Home/Filings/4/0001104659-25-063693
4//SEC Filing

Fain Eric S 4

Accession 0001104659-25-063693

CIK 0001814114other

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 5:10 PM ET

Size

5.7 KB

Accession

0001104659-25-063693

Insider Transaction Report

Form 4
Period: 2025-06-26
Fain Eric S
Director
Transactions
  • Sale

    Common Stock, par value $0.0001 per share ("Common Stock")

    2025-06-26$3.05/sh2,683$8,18350,949 total(indirect: By Trust)
Footnotes (2)
  • [F1]The shares reported as disposed herein were granted on June 20, 2024 as restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
  • [F2]The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.98 to $3.11, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Orchestra BioMed Holdings, Inc.

CIK 0001814114

Entity typeother

Related Parties

1
  • filerCIK 0001402222

Filing Metadata

Form type
4
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 5:10 PM ET
Size
5.7 KB